THE CLINICAL PHARMACOLOGY OF POSTGANGLIONIC SYMPATHETIC BLOCKING AGENTS.
D000959:Antihypertensive Agents; D001949:Bretylium Compounds; D005730:Ganglionic Blockers; D006145:Guanethidine; D008660:Metabolism; D008750:Methyldopa; D009482:Neurophysiology; D009638:Norepinephrine; D010293:Pargyline; D010600:Pharmacology; D011817:Rabbits; D051381:Rats; D012106:Research; D012110:Reserpine; D013564:Sympathetic Nervous System; D013565:Sympatholytics
D000959:Antihypertensive Agents; D001949:Bretylium Compounds; D005730:Ganglionic Blockers; D013565:Sympatholytics; D008750:Methyldopa; D012110:Reserpine; D010293:Pargyline; D009638:Norepinephrine; D006145:Guanethidine
ANTIHYPERTENSIVE AGENTS; BRETYLIUM COMPOUNDS; EXPERIMENTAL LAB STUDY; GANGLIONIC BLOCKADERS; GUANETHIDINE; METABOLISM; METHYLDOPA; NEUROPHYSIOLOGY; NOREPINEPHRINE; PARGYLINE; PHARMACOLOGY; RABBITS; RATS; RESERPINE; SYMPATHETIC NERVOUS SYSTEM